BiotechTube
Telios Pharma

Telios Pharma

San Diego, United States· Est.
teliospharma.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $35M

Overview

Telios Pharma is a private, pre-revenue biotech founded in 2018, operating in the small molecule therapeutics space. As a clinical-stage company, it is advancing its pipeline through early-phase trials, though specific program details are not publicly disclosed on its minimal website. The company's lean structure and focused approach suggest it is in a capital-intensive R&D phase, seeking to validate its candidates and attract partnership or investment.

Small Molecules

Technology Platform

Not publicly disclosed. Likely small molecule drug discovery and optimization.

Funding History

1
Total raised:$35M
Series A$35M

Opportunities

The opportunity lies in successfully advancing its undisclosed clinical-stage asset(s) to generate positive proof-of-concept data, which could enable partnership deals or further investment.
Operating in the vast small molecule space allows for targeting large, validated markets if the science is compelling.

Risk Factors

Primary risks include clinical failure of its lead candidate(s), inability to secure necessary funding to continue trials, and intense competition in any chosen therapeutic area.
The lack of public information creates significant uncertainty for external evaluation.

Competitive Landscape

Competition is undefined without knowledge of the company's therapeutic focus. As a small molecule developer, it would compete with countless other biotechs and large pharma companies across all disease areas, making target selection and differentiation critical.

More companies in Small Molecule Drugs →More companies in United States →